Xiu Qiu has completed her PhD of Maternal, Children and Adolescents Health from the Chinese Center for Disease Control and Prevention, Beijing, China. She is the Director and a Principle Investigator in Born in Guangzhou Cohort Study. She has broad research interests in the epidemiology of maternal and child health, including gestational diabetes, preterm birth, fetal growth, child development. She has coauthored of over 30 publications including Lancet, Environmental Health Perspectives, European Journal of Epidemiology, GigaScience, Ebiomedicine etc.
Abstract
Objective: To explore relationships between gestational weight gain rate (GWGR) and adverse perinatal outcomes in a large population from a developing country.Methods: Prospective data from 17181 pregnant women in the Born in Guangzhou Cohort Study, China was included. GWGR (kg/week) was calculated by dividing the total GWG (kg) by gestational weeks at which the maternal weight at delivery was measured. Stratified by pre-pregnancy BMI sub-groups (<18.5, 18.5-24.9, and ≥25kg/m2), associations between GWGR and preterm birth, cesarean delivery and neonatal asphyxia (Apgar score at 1 minute ≤7) were examined using logistic regression.
Results: The proportions of underweight, normal weight, and overweight/obese prior to pregnancy were 23.8%, 70.0%, and 6.2%. The mean GWGRs of these three groups were 379.79g/week, 367.71g/week, 301.78 g/week, respectively. Among underweight mothers, high weight gain rate (>mean+1 SD) was associated with an increased risk of preterm birth (OR [95%CI], 1.59 [1.01-2.52]) and caesarean section (1.49[1.21-1.83]) compared to adequate GWGR (mean±1SD). For mothers with normal weight, low weight gain rate (
Conclusion: Both high and low weight gain rate was associated with adverse perinatal outcomes.
Medicinal Chemistry
Synthetic V/S Bio organic Chemistry
High -Throughput Screening & Combinatorial Chemistry
Pharmacogenomics
Anticancer Agents in Medicinal Chemistry
Industrial Aspects of Pharmaceutical Chemistry
GPCRs and Targeted Drug Delivery
GPCRs in HIV infection
Emerging Drugs and Their Targets
Drug Structure-Activity Relationships
Compound Diversity Measurements
Current Developments in Rational Drug Design
Drug Absorption, Distribution, Metabolism & Excretion (ADME)